Skip to content
20-F

Annual Report (Foreign)

Akso Health Group AHG

0001213900-25-076862

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Mar 31, 2025 855.29M sh
Shares Diluted FY 2025 · Mar 31, 2024 141.52M sh
Shares Diluted FY 2025 · Mar 31, 2023 68.6M sh
Shares Outstanding FY 2025 · Mar 31, 2025 1.66B sh
Capex FY 2025 · Mar 31, 2025 $154.46K
Operating Cash Flow FY 2025 · Mar 31, 2025 $1.18M
Operating Cash Flow FY 2025 · Mar 31, 2024 $1.35M
Operating Cash Flow FY 2025 · Mar 31, 2023 −$3.25M
Cash And Equivalents FY 2025 · Mar 31, 2025 $176.23M
Cash And Equivalents FY 2025 · Mar 31, 2024 $85.17M
Cash And Equivalents FY 2025 · Mar 31, 2023 $7.92M
Stockholders Equity FY 2025 · Mar 31, 2025 $199.12M
Stockholders Equity FY 2025 · Mar 31, 2024 $138.37M
Current Liabilities FY 2025 · Mar 31, 2025 $13.81M
Current Liabilities FY 2025 · Mar 31, 2024 $3.59M
Total Liabilities FY 2025 · Mar 31, 2025 $15.8M
Total Liabilities FY 2025 · Mar 31, 2024 $3.59M
Current Assets FY 2025 · Mar 31, 2025 $196.12M
Current Assets FY 2025 · Mar 31, 2024 $142.02M
Total Assets FY 2025 · Mar 31, 2025 $214.95M
Total Assets FY 2025 · Mar 31, 2024 $142.02M
Eps Diluted FY 2025 · Mar 31, 2025 −$0.16
Eps Diluted FY 2025 · Mar 31, 2024 −$0.07
Eps Diluted FY 2025 · Mar 31, 2023 −$0.02
Eps Basic FY 2025 · Mar 31, 2025 −$0.16
Eps Basic FY 2025 · Mar 31, 2024 −$0.07
Eps Basic FY 2025 · Mar 31, 2023 −$0.02
Sga Expense FY 2025 · Mar 31, 2025 $3.64M
Sga Expense FY 2025 · Mar 31, 2024 $8.59M
Net Income FY 2025 · Mar 31, 2025 −$134.98M
Net Income FY 2025 · Mar 31, 2024 −$9.46M
Net Income FY 2025 · Mar 31, 2023 −$1.36M
Operating Income FY 2025 · Mar 31, 2025 −$166.3M
Operating Income FY 2025 · Mar 31, 2024 −$8.64M
Operating Income FY 2025 · Mar 31, 2023 −$14.27M
Gross Profit FY 2025 · Mar 31, 2025 −$281.53K
Gross Profit FY 2025 · Mar 31, 2024 $122.13K
Gross Profit FY 2025 · Mar 31, 2023 $1.27M
Cost Of Revenue FY 2025 · Mar 31, 2025 $15.06M
Cost Of Revenue FY 2025 · Mar 31, 2024 $2.29M
Cost Of Revenue FY 2025 · Mar 31, 2023 $11.91M